Health Economics & Value
Demonstrating the Economic Benefit of Healthcare Products
A rising pressure to control the increasing cost of healthcare necessitates a greater need to demonstrate the value of healthcare and medical treatments. Health Economics and Outcomes Research (HEOR) analytics plays a key role in drug approval, reimbursement, and formulary listing.
It enables you to evaluate the cost of medical interventions and the overall economic burden of healthcare. Furthermore, HEOR facilitates the quantification of associated outcomes.
HOW WE HELP
Positively Impacting Patient Lives
The Bioviser team generates compelling evidence that empowers you to make informed, critical decisions to positively impact patient lives. We research current market demands and evaluate the economic worth of new healthcare products.
Our team helps establish product value through literature reviews, database analyses, development of pharmaceutical and ROI models, meta-analyses, and patient-reported outcomes. You can also avail of our competitor profiling service and access our value communication tool to gain an advantage.
Health Economics & Value Deliverables
- Systematic reviews of comparative efficacy and effectiveness, often with relevant data synthesis techniques [meta-analytical approaches]
- Burden of disease reviews – clinical, humanistic and economic
- Health technology assessment [HTA] & payer landscaping
- Reviews of treatment guidelines and care pathways
- Targeted literature reviews
- Payer and/or expert interviews, Delphi panels and focus groups
- Network meta-analyses and indirect treatment comparisons
- Overall commercial forecasts
- Net Present Value Analysis
- Burden of disease: Overall and for high-risk groups
- Survival modelling and extrapolation
- Statistical modeling in R
- Cost-effectiveness and cost-utility models
- Budget impact models
- HTA and reimbursement submissions
- Value dossiers
- Payer communication tools
- Conference presentations
- Training and workshops
- Internal communication aids
WHAT WE OFFER
The Bioviser Advantage
Systematic Literature Reviews of comparative efficacy, safety, and effectiveness through Evidence Reviews. This includes relevant data synthesis techniques [meta-analytical approaches]. We also perform targeted reviews along with burden of disease reviews that comprise clinical, humanistic, and economic outcomes. This offering gives you critical insights through network meta-analyses and indirect treatment comparisons. Moreover, Bioviser experts offer Health technology assessment [HTA] and payer landscaping, reviews of treatment guidelines and care pathways, and payer and/or expert interviews, Delphi panels, and focus groups. We provide comprehensive qualitative and quantitative findings and interpretations through the reviews and make necessary recommendations.
We conduct Evidence Synthesis where we create commercial forecasts, net present value analysis, and burden of disease evaluations for both overall patient cohort and high-risk groups. Our experts use appropriate statistical models to design cost-effectiveness models and survival models. To help you make crucial economic decisions, we create budget impact models that include cohort-specific models and individual patient-level simulations, core (global) economic models or HTA agency-specific models, and early planning models.
Another valued HEOR service offered by Bioviser includes Evidence Communication. You can expect submission-ready HTA and reimbursement value dossiers and publications. We also offer payer communication tools, conference presentations, training and workshop, and internal communication aids.
Fast and Flexible Team
Our team is flexible, fast, responsive, and ready to accommodate your unique requirements. With customized and stress-free collaboration, we will help you fulfill your HEOR needs and deliver quality insights across all facets of HEOR.
WHAT MAKES US COMPETITIVE
Partner with Bioviser
Well-trained, qualified analysts
(MD, MS, PhD)
Collaborate with the best in the industry